Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5

Preferred Label : Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5;

NCIt synonyms : Meconium Antigen 100; Carcinoembryonic Antigen; CEACAM5; CD66E Antigen;

NCIt related terms : CEA;

NCIt definition : Carcinoembryonic antigen-related cell adhesion molecule 5 (702 aa, 77 kDa) is encoded by the human CEACAM5 gene. This protein is involved in cell-cell adhesion, apotosis regulation and signaling.;

Détails

Origin ID

C16384;

UMLS CUI

C2352715;

Currated CISMeF NLP mapping
- CD66e Ag [LOINC component]
- Carcinoembryonic Ag [LOINC component]
- Carcinoembryonic antigen [MedDRA Preferred Term]
- carcinoembryonic antigen [EMDN type]
- carcinoembryonic antigen [MeSH Descriptor]
- carcinoembryonic antigen [MeSH concept]
- carcinoembryonic antigen [SNOMED Notion]
False automatic mappings
- Carcinoembryonic antigen (substance) [SNOMED CT concept]
OMIM relation
- Cea cell adhesion molecule 5 [OMIM gene]
See also inter- (CISMeF)
- Carcinoembryonic antigen present (finding) [SNOMED CT concept]
Semantic type(s)
- Amino Acid, Peptide, or Protein [UMLS semantic type]
- Immunologic Factor [UMLS semantic type]
UMLS correspondences (same concept)
- CD66e Ag [LOINC component]
- CEACAM5 protein, human [MeSH concept]
- CEACAM5 protein, human [MeSH Supplementary Concept]
- Carcinoembryonic Ag [LOINC component]
- Carcinoembryonic antigen (substance) [SNOMED CT concept]
- carcinoembryonic antigen [MeSH concept]
- carcinoembryonic antigen [MeSH Descriptor]
- carcinoembryonic antigen [SNOMED Notion]
- lymphocyte antigen cd66e [SNOMED Notion]
concept_is_in_subset
- CTRP Biomarker Terminology [NCIt concept]
- CTRP Molecular Genetic Biomarker Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
gene_encodes_gene_product
- CEACAM5 Gene [NCIt concept]
- Cell Adhesion Molecule Gene [NCIt concept]
- Ligand Binding Protein Gene [NCIt concept]
gene_product_expressed_in_tissue
- CD8-Positive T-Lymphocyte [NCIt concept]
- Epithelial Cell [NCIt concept]
gene_product_has_associated_anatomy
- Plasma Membrane [NCIt concept]
gene_product_has_biochemical_function
- Carcinoembryonic Antigen [NCIt concept]
gene_product_has_chemical_classification
- Glycoprotein [NCIt concept]
gene_product_has_organism_source
- Human [NCIt concept]
gene_product_has_structural_domain_or_motif
- Ligand Binding Domain [NCIt concept]
- N Domain [NCIt concept]
gene_product_is_biomarker_type
- Cluster of Differentiation [NCIt concept]
- Tumor Marker [NCIt concept]
gene_product_plays_role_in_biological_process
- Cell Adhesion Process [NCIt concept]
- Ligand Binding [NCIt concept]
is_target
- Actinium Ac 225-DOTA-anti-CEA Monoclonal Antibody M5A [NCIt concept]
- Adenoviral Vector Ad5-CEA(6D) Vaccine [NCIt concept]
- Adenovirus 5 CEA/MUC1/Brachyury Vaccine Tri-Ad5 [NCIt concept]
- Anti-CEA BiTE Monoclonal Antibody AMG211 [NCIt concept]
- Anti-CEA CAR T Cells [NCIt concept]
- Anti-CEA-CAR Autologous T Lymphocytes [NCIt concept]
- Anti-CEA/Anti-4-1BB Bispecific Antibody BGB-B167 [NCIt concept]
- Anti-CEA/Anti-4-1BB Bispecific Antibody LM-24C5 [NCIt concept]
- Anti-CEA/Anti-CD3 Bispecific Antibody BA1202 [NCIt concept]
- Anti-CEA/Anti-CEACAM6 Antibody-drug Conjugate EBC-129 [NCIt concept]
- Anti-CEA/Anti-DR5 Bispecific Antibody IBI3004 [NCIt concept]
- Anti-CEACAM5 ADC SGN-CEACAM5C [NCIt concept]
- Anti-CEACAM5 Antibody-drug Conjugate BG-C477 [NCIt concept]
- Autologous Anti-CEA CAR/HLA-A*02-gated Inhibitory Receptor/B2M shRNA-expressing T-lymphocytes A2B530 [NCIt concept]
- CEA-MUC-1-TRICOM Vaccine CV301 [NCIt concept]
- CEA-targeting Agent RG6123 [NCIt concept]
- Carcinoembryonic Antigen Peptide 1-6D Virus-Like Replicon Particles Vaccine [NCIt concept]
- Carcinoembryonic Antigen RNA-pulsed DC Cancer Vaccine [NCIt concept]
- Carcinoembryonic Antigen-Expressing Measles Virus [NCIt concept]
- Cibisatamab [NCIt concept]
- Copper Cu 64 Anti-CEA Monoclonal Antibody M5A [NCIt concept]
- FPV Vaccine CV301 [NCIt concept]
- Iodine I 123 Anti-CEA Recombinant Diabody T84.66 [NCIt concept]
- Iodine I 124 Monoclonal Antibody M5A [NCIt concept]
- Labetuzumab Govitecan [NCIt concept]
- Multi-neo-epitope Vaccine OSE 2101 [NCIt concept]
- Precemtabart Tocentecan [NCIt concept]
- Prime Cancer Vaccine MVA-BN-CV301 [NCIt concept]
- Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207 [NCIt concept]
- Synthetic Breast Cancer Peptides-Tetanus Toxoid-Poly ICLC Vaccine [NCIt concept]
- Tusamitamab Ravtansine [NCIt concept]
- Yttrium Y 90 Anti-CEA Monoclonal Antibody cT84.66 [NCIt concept]
- Yttrium Y 90 DOTA Anti-CEA Monoclonal Antibody M5A [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients